177 related articles for article (PubMed ID: 35402260)
1. TRIM65 Promotes Cervical Cancer Through Selectively Degrading p53-Mediated Inhibition of Autophagy and Apoptosis.
Wang XY; Mao HW; Guan XH; Huang QM; Yu ZP; Wu J; Tan HL; Zhang F; Huang X; Deng KY; Xin HB
Front Oncol; 2022; 12():853935. PubMed ID: 35402260
[TBL] [Abstract][Full Text] [Related]
2. TRIM65 negatively regulates p53 through ubiquitination.
Li Y; Ma C; Zhou T; Liu Y; Sun L; Yu Z
Biochem Biophys Res Commun; 2016 Apr; 473(1):278-282. PubMed ID: 27012201
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of TRIM65 inhibits autophagy and cisplatin resistance in A549/DDP cells by regulating miR-138-5p/ATG7.
Pan X; Chen Y; Shen Y; Tantai J
Cell Death Dis; 2019 Jun; 10(6):429. PubMed ID: 31160576
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin ligase TRIM65 promotes colorectal cancer metastasis by targeting ARHGAP35 for protein degradation.
Chen D; Li Y; Zhang X; Wu H; Wang Q; Cai J; Cui Y; Liu H; Lan P; Wang J; Yang Z; Wang L
Oncogene; 2019 Sep; 38(37):6429-6444. PubMed ID: 31332286
[TBL] [Abstract][Full Text] [Related]
5. TRIM65 E3 ligase targets VCAM-1 degradation to limit LPS-induced lung inflammation.
Li Y; Huang X; Guo F; Lei T; Li S; Monaghan-Nichols P; Jiang Z; Xin HB; Fu M
J Mol Cell Biol; 2020 Apr; 12(3):190-201. PubMed ID: 31310649
[TBL] [Abstract][Full Text] [Related]
6. TRIM65 promotes renal cell carcinoma through ubiquitination and degradation of BTG3.
Zhang Q; Li Y; Zhu Q; Xie T; Xiao Y; Zhang F; Li N; Deng K; Xin H; Huang X
Cell Death Dis; 2024 May; 15(5):355. PubMed ID: 38777825
[TBL] [Abstract][Full Text] [Related]
7. TRIM65 triggers β-catenin signaling via ubiquitylation of Axin1 to promote hepatocellular carcinoma.
Yang YF; Zhang MF; Tian QH; Zhang CZ
J Cell Sci; 2017 Sep; 130(18):3108-3115. PubMed ID: 28754688
[TBL] [Abstract][Full Text] [Related]
8. E3 ligase TRIM65 alleviates intestinal ischemia/reperfusion injury through inhibition of TOX4-mediated apoptosis.
Huang Y; Chen T; Jiang M; Xiong C; Mei C; Nie J; Zhang Q; Zhu Q; Huang X; Zhang X; Li Y
Cell Death Dis; 2024 Jan; 15(1):29. PubMed ID: 38212319
[TBL] [Abstract][Full Text] [Related]
9. The Magic and Mystery of TRIM65 in Diseases.
Zhou Q; Li Y; Zhou Z; Zhou Y; Liu Y; Liu W; Ma X
Curr Med Chem; 2024 Jun; ():. PubMed ID: 38939997
[TBL] [Abstract][Full Text] [Related]
10. The E3 Ubiquitin Ligase TRIM65 Negatively Regulates Inflammasome Activation Through Promoting Ubiquitination of NLRP3.
Tang T; Li P; Zhou X; Wang R; Fan X; Yang M; Qi K
Front Immunol; 2021; 12():741839. PubMed ID: 34512673
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of TRIM65 suppressed the proliferation and invasiveness of gastric cancer cells by restricting the ubiquitin degradation of PPM1A.
Liu C; Sun W; Yang K; Xia B
Exp Cell Res; 2022 Jul; 416(2):113154. PubMed ID: 35421368
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of TRIM65 inhibits lung cancer cell proliferation, migration and invasion: A therapeutic target in human lung cancer.
Wang XL; Shi WP; Shi HC; Lu SC; Wang K; Sun C; He JS; Jin WG; Lv XX; Zou H; Shu YS
Oncotarget; 2016 Dec; 7(49):81527-81540. PubMed ID: 27829229
[TBL] [Abstract][Full Text] [Related]
13. TRIM65 is a potential oncogenic protein via ERK1/2 on Jurkat and Raji cells: A therapeutic target in human lymphoma malignancies.
Wang J; Liang X; Yu T; Xu YL; Xu LH; Zhang XJ; Ma J; Wang YR; He SL
Cell Biol Int; 2018 Nov; 42(11):1503-1510. PubMed ID: 30039885
[TBL] [Abstract][Full Text] [Related]
14. Trim65 attenuates isoproterenol-induced cardiac hypertrophy by promoting autophagy and ameliorating mitochondrial dysfunction via the Jak1/Stat1 signaling pathway.
Liu H; Zhou Z; Deng H; Tian Z; Wu Z; Liu X; Ren Z; Jiang Z
Eur J Pharmacol; 2023 Jun; 949():175735. PubMed ID: 37080331
[TBL] [Abstract][Full Text] [Related]
15. TRIM65 supports bladder urothelial carcinoma cell aggressiveness by promoting ANXA2 ubiquitination and degradation.
Wei WS; Chen X; Guo LY; Li XD; Deng MH; Yuan GJ; He LY; Li YH; Zhang ZL; Jiang LJ; Chen RX; Ma XD; Wei S; Ma NF; Liu ZW; Luo JH; Zhou FJ; Xie D
Cancer Lett; 2018 Oct; 435():10-22. PubMed ID: 30075204
[TBL] [Abstract][Full Text] [Related]
16. TRIM65 Promotes Invasion of Endometrial Stromal Cells by Activating ERK1/2/C-myc Signaling via Ubiquitination of DUSP6.
Wu YT; Ma SY; Sun WQ; Shen WW; Zhu HT; Zhang Q; Chen HF
J Clin Endocrinol Metab; 2021 Jan; 106(2):526-538. PubMed ID: 33146694
[TBL] [Abstract][Full Text] [Related]
17. Combinatory inhibition of TRIM65 and MDM2 in lung cancer cells.
Chen G; Zhou T; Liu Y; Yu Z
Biochem Biophys Res Commun; 2018 Nov; 506(3):698-702. PubMed ID: 30454706
[TBL] [Abstract][Full Text] [Related]
18. TRIM65 in White Matter Lesions, Innate Immunity, and Tumor.
Liu B; Tang Y; Yang P; Wu C; Huang Y
Curr Mol Pharmacol; 2021; 14(5):798-805. PubMed ID: 33538683
[TBL] [Abstract][Full Text] [Related]
19. TRIM65 regulates microRNA activity by ubiquitination of TNRC6.
Li S; Wang L; Fu B; Berman MA; Diallo A; Dorf ME
Proc Natl Acad Sci U S A; 2014 May; 111(19):6970-5. PubMed ID: 24778252
[TBL] [Abstract][Full Text] [Related]
20. Tripartite motif-containing protein 26 promotes colorectal cancer growth by inactivating p53.
Lu H; Tan Z; Ko H; Naji P; Zhu R; Wang J; Huang S; Zhang YW; Zeng S
Res Sq; 2024 Jan; ():. PubMed ID: 38260302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
